| 1 | Aβ-first AD pathology h-443c02857991 | — | — | — | — | | 2026-04-30 | | Trade → |
| 2 | Aβ-first AD pathology h-91ac58830257 | — | — | — | — | | 2026-04-30 | | Trade → |
| 3 | Tau-first AD pathology h-e18e2da6318d | — | — | — | — | | 2026-04-30 | | Trade → |
| 4 | Tau-first AD pathology h-af6bab0d98df | — | — | — | — | | 2026-04-30 | | Trade → |
| 5 | Tau-first AD pathology h-85096cb1072e | — | — | — | — | | 2026-04-30 | | Trade → |
| 6 | Tau-first AD pathology h-bbbe661eea8a | — | — | — | — | | 2026-04-29 | | Trade → |
| 7 | Tau-first AD pathology h-fe4ba01b4433 | — | — | — | — | | 2026-04-30 | | Trade → |
| 8 | Tau-first AD pathology h-30d85a30f154 | — | — | — | — | | 2026-04-30 | | Trade → |
| 9 | Tau-first AD pathology h-b52f6e00cc58 | — | — | — | — | | 2026-04-29 | | Trade → |
| 10 | Aβ-first AD pathology h-0e4b805ee9fb | — | — | — | — | | 2026-04-30 | | Trade → |
| 11 | Valid Hypothesis Title h-b07f212f4a8c | — | — | — | — | | 2026-04-30 | | Trade → |
| 12 | Valid Title h-fd16ffa06c6f | — | — | — | — | | 2026-04-30 | | Trade → |
| 13 | eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Protein Import and Bioen… h-var-501d347dbb | EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import | — | — | — | | 2026-04-28 | | Trade → |
| 14 | Tau-first AD pathology h-ca9ea13d7db4 | — | — | — | — | | 2026-04-30 | | Trade → |
| 15 | MGnD/DAM microglia expansion precedes mature oligodendrocyte depletion across B… 61e09415-db69-4211-a262-cab93358da3e | — | — | — | — | | 2026-05-30 | | Trade → |
| 16 | Tau-first AD pathology h-4ba18a4d1c4b | — | — | — | — | | 2026-04-30 | | Trade → |
| 17 | Aβ-first AD pathology h-108aadf2120f | — | — | — | — | | 2026-04-29 | | Trade → |
| 18 | Aβ-first AD pathology h-62a63e1c06a9 | — | — | — | — | | 2026-04-29 | | Trade → |
| 19 | MGnD expansion and oligodendrocyte loss are coupled and sequentially ordered in… 7a198e28-0fc7-4010-b889-afa577ca4ae4 | — | — | — | — | | 2026-05-30 | | Trade → |
| 20 | Clean readable hypothesis title 159 q1 h-71f0784f41ef | — | — | — | — | | 2026-04-29 | | Trade → |
| 21 | Aβ-first AD pathology h-85bd4d63445b | — | — | — | — | | 2026-04-30 | | Trade → |
| 22 | Aβ-first AD pathology h-3a9654b45f84 | — | — | — | — | | 2026-04-30 | | Trade → |
| 23 | Alpha-theta entrainment therapy to enhance default mode network coherence h-var-08841db86a | SST | — | — | — | | 2026-04-28 | | Trade → |
| 24 | Aβ-first AD pathology h-d9d324ca3b66 | — | — | — | — | | 2026-04-30 | | Trade → |
| 25 | Tau-first AD pathology h-526f0d935d77 | — | — | — | — | | 2026-04-29 | | Trade → |
| 26 | DAM/MGnD microglia expansion precedes oligodendrocyte/OPC depletion in AD corte… fa361122-8512-425f-8da9-6061863fe626 | — | — | — | — | | 2026-05-30 | | Trade → |
| 27 | test 8f9fed28-6c0b-49b4-a797-c2012f1a0ee7 | — | — | — | — | | 2026-05-24 | | Trade → |
| 28 | DAM/MGnD expansion precedes oligodendroglial depletion across Braak stages in A… 27c0b993-f18d-4e32-9bee-e2478772a946 | — | — | — | — | | 2026-05-31 | | Trade → |
| 29 | BRCA1 RING domain E3 ligase activity is essential for homologous recombination… h-demo-brca1-hr-repair | — | — | — | — | | 2026-05-16 | | Trade → |
| 30 | GBO Hypothesis: Simultaneous Wide-FOV Calcium + Neuropixels Can Distinguish Rec… c1e023d5-fd01-4f9b-b30a-3d9f63adf12c | — | — | — | — | | 2026-05-24 | | Trade → |
| 31 | Runtime probe hypothesis 18200 h-51735593929e | — | — | — | — | | 2026-05-16 | | Trade → |
| 32 | Hypothesis: Structured beta-test evaluation improves SciDEX v2 design trajector… a2f28998-4a2b-48b9-990c-f89b1a19fa3c | — | — | — | — | | 2026-05-24 | | Trade → |
| 33 | mTORC1 inhibition extends healthy lifespan by reducing ribosome biogenesis and… h-demo-mtor-longevity | — | — | — | — | | 2026-05-16 | | Trade → |
| 34 | Aβ-first AD pathology h-f94f3b4655ae | — | — | — | — | | 2026-04-30 | | Trade → |
| 35 | Aβ-first AD pathology h-0751343cd522 | — | — | — | — | | 2026-04-29 | | Trade → |
| 36 | TBK1 Loss Triggers eIF2α-Mediated Translational Repression Through Microglial S… h-var-a7e2e13faf | TBK1, EIF2S1 | — | — | — | | 2026-04-28 | | Trade → |
| 37 | GBO trajectory test hypothesis dd5a7f56-3089-40a6-832e-b0b5868180b5 | — | — | — | — | | 2026-05-24 | | Trade → |
| 38 | Tau-first AD pathology h-3e3f27c75a38 | — | — | — | — | | 2026-04-30 | | Trade → |
| 39 | GSK-3β-mediated tau hyperphosphorylation is the primary driver of neurofibrilla… h-demo-tau-hyperphosphorylation | — | — | — | — | | 2026-05-16 | | Trade → |
| 40 | test fccab4a7-2463-4bf6-b9e8-20ff59bdc21f | — | — | — | — | | 2026-05-16 | | Trade → |
| 41 | Closed-loop transcranial focused ultrasound with gamma entrainment to restore h… h-var-cedb86877e | PVALB | — | — | — | | 2026-04-28 | | Trade → |
| 42 | Aβ-first AD pathology h-4713bcb43344 | — | — | — | — | | 2026-04-30 | | Trade → |
| 43 | Tau-first AD pathology h-652d58c6248a | — | — | — | — | | 2026-04-30 | | Trade → |
| 44 | MGnD microglia expansion precedes OPC depletion across the Braak trajectory in… cc20ae25-3d6c-4ac9-99a2-8dc1f3d75319 | — | — | — | — | | 2026-05-31 | | Trade → |
| 45 | MGnD microglia expansion is upstream of oligodendrocyte depletion in late-Braak… b4a84c55-2dc9-4d63-910a-6c8a7b0cbb9f | — | — | — | — | | 2026-05-30 | | Trade → |
| 46 | Hypothesis: Structured beta-test evaluation improves SciDEX v2 design trajector… 3b6b852d-6e8a-414a-99d8-288d9a1be3fc | — | — | — | — | | 2026-05-24 | | Trade → |
| 47 | SpCas9 PAM-distal seed-region mismatches are the dominant predictor of off-targ… h-demo-crispr-off-target | — | — | — | — | | 2026-05-16 | | Trade → |
| 48 | Gut microbiome dysbiosis drives neuroinflammation via the vagus nerve–enteric–b… h-demo-gut-brain-axis | — | — | — | — | | 2026-05-16 | | Trade → |
| 49 | Aβ-first AD pathology h-b84eaf2565e5 | — | — | — | — | | 2026-04-30 | | Trade → |
| 50 | Tau-first AD pathology h-b08996d03599 | — | — | — | — | | 2026-04-30 | | Trade → |